Last $0.14 USD
Change Today 0.00 / 0.00%
Volume 0.0
PRNAF On Other Exchanges
Symbol
Exchange
NASDAQ CM
Berlin
OTC US
Stuttgart
As of 8:10 PM 02/17/15 All times are local (Market data is delayed by at least 15 minutes).

prana biotechnology ltd (PRNAF) Key Developments

Prana Biotechnology Limited Reports Consolidated Earnings Results for the Half Year Ended December 31, 2014

Prana Biotechnology Limited reported consolidated earnings results for the half year ended December 31, 2014. For the period, the company reported loss after income tax of AUD 1,252,695 compared to AUD 7,928,392 for the same period a year ago. Revenue from ordinary activities was AUD 92,581 compared to AUD 189,588 a year ago. Loss before income tax expense was AUD 1,252,695 compared to AUD 7,928,392 a year ago. Basic and diluted loss per share was 0.26 cents compared to 1.97 cents a year ago. Net operating cash flows were AUD 8,411,407 compared to AUD 7,435,475 a year ago. Payment for purchases of plant and equipment was AUD 24,942 compared to AUD 12,718 a year ago. The loss has decreased compared to previous year due to a gain on foreign exchange, an increase in other income related to the R&D Tax Concession and a decrease in expenditure on research and development.

Prana Biotechnology Limited - Shareholder/Analyst Call

Annual General Meeting

Prana Biotechnology Limited Announces Executive Changes

Prana Biotechnology Limited announced the appointment of Ms. Kathryn Andrews as Chief Financial Officer and Mr. Phillip Hains as Company Secretary. Ms Andrews is a Certified Practicing Accountant and has over 25 years' experience in accounting, commercial management and consulting in various roles. For the past two years Ms. Andrews has held a senor role with The CFO Solution. As principal of The CFO Solution since 1996, Mr. Hains is the Company Secretary for a number of listed companies in the life sciences sector. The appointment follows the resignation of Mr. Richard (Rick) Revelins from the role of CFO and Company Secretary to pursue other commercial interests in the USA. The changes are effective immediately.

Prana Biotechnology Limited announced delayed 20-F filing

On 10/31/2014, Prana Biotechnology Limited announced that they will be unable to file their next 20-F by the deadline required by the SEC.

Prana Biotechnology Limited, Annual General Meeting, Nov 13, 2014

Prana Biotechnology Limited, Annual General Meeting, Nov 13, 2014., at 11:30 AUS Eastern Standard Time. Location: Giorgios Restaurant Function Room. Agenda: To receive and consider the 2014 annual financial statements of the company in respect of the year ended 30 June 2014 and comprising the annual financial report, the directors’ report and the auditor’s report; to approve executive changes; to approve ratification of previously issued securities-ATM; and to consider any other business that may be brought before the meeting in accordance with the constitution of the company and the Corporations Act.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PRNAF:US $0.14 USD 0.00

PRNAF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PRNAF.
View Industry Companies
 

Industry Analysis

PRNAF

Industry Average

Valuation PRNAF Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.5x
Price/Book 1.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PRANA BIOTECHNOLOGY LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.